A study led by The University of Western Australia has found a simple screening test to identify at-risk prisoners could reduce hospitalizations related to substance use, providing relief for a health system already under ...
Oct 24, 2023
0
0
The Academy of Breastfeeding Medicine (ABM) has released new literature-based recommendations related to breastfeeding in the setting of substance use and substance use disorder (SUD) treatments. The new clinical protocol ...
Oct 23, 2023
0
1
Mental health crises among children and adolescents requiring emergency department care skyrocketed during the pandemic and have stayed elevated despite a return to normalcy, according to a study by Weill Cornell Medicine ...
Oct 20, 2023
0
0
Tattoo removal may help to reduce violence and trauma in East Los Angeles, according to study results being presented at the American College of Surgeons (ACS) Clinical Congress 2023.
Oct 20, 2023
0
0
An international consortium of multidisciplinary researchers and specialists has developed a new method to counter the problem of COVID-19 vaccine falsification.
Oct 20, 2023
0
0
What changes in the brains of people who commit or think about committing suicide? Ph.D. candidate Lin Zhang investigated at a molecular level the processes that take place in the human brain during suicide. The hope is that ...
Oct 19, 2023
0
0
Starting buprenorphine treatment for opioid use disorder through telehealth was associated with an increased likelihood of staying in treatment longer compared to starting treatment in a non-telehealth setting, according ...
Oct 18, 2023
0
12
Highly vulnerable patients with alcohol use disorder (AUD) or substance use disorder (SUD) who received regular assessments after their initial intervention had substantially better outcomes a year later than those who did ...
Oct 17, 2023
0
0
The Netflix series "Painkiller" recently depicted how the over-prescribing of the medicine OxyContin wreaked havoc on American society.
Oct 17, 2023
0
0
Research led by the New York State Psychiatric Institute, New York, has looked into non-medical lysergic acid diethylamide (LSD) use by people with major depression status and their sociodemographic characteristics.
